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Abstract: 
Human thiopurine S-methyltransferase (TPMT) is an essential protein in 6-mercaptopurine (6MP) drug metabolism. To understand the 
pharmacogenetics of TPMT and 6MP, X-ray co-crystal structures of TPMT complexes with S-adenosyl-L-methionine (AdoMet) and 6MP 
are required. However, the co-crystal structure of this complex has not been reported because 6MP is poorly water soluble. We used 
molecular dynamics (MD) simulation to predict the structure of the complex of human TPMT-AdoHcy(CH2)6MP, where the sulfur atoms of 
AdoHcy and 6MP were linked by a CH2 group. After 1300 picoseconds of MD simulation, the trajectory showed that 6MP was stabilized in 
the TPMT active site by formation of non-bonded interactions between 6MP and Phe40, Pro196 and Arg226 side chains of TPMT. The 
intersulfur distance between AdoHcy and 6MP as well as the binding modes and the interactions of our TPMT-AdoHcy model are 
consistent with those observed in the X-ray crystal structure of murine TPMT-AdoHcy-6MP complex. The predicted binding modes of 
AdoHcy and 6MP in our model are consistent with those observed in murine TPMT X-ray crystal structures, which provides structural 
insights into the interactions of TPMT, AdoHcy, and 6MP at the atomic level and may be used as a starting point for further study of 
thiopurine drug pharmacogenetics. 
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Background: 
Thiopurine drugs including 6-mercaptopurine (6MP), 6-
thioguanine, and azathioprine have wide clinical applications 
ranging from immunosuppressants for preventing graft-rejection in 
organ transplant patients, to treatment of diseases such as childhood 
acute lymphoblastic leukemia, autoimmune disorder, and 
inflammatory bowel disease [1-3]. The toxicity of these drugs is 
ameliorated by conversion to methylated forms by the thiopurine S- 
methyltransferase enzyme (TPMT), which uses S-adenosyl-L-
methionine (AdoMet), as a methyl donor. As a result of the transfer 
of the methyl group, AdoMet is converted to S-
adenosylhomocysteine (AdoHcy). Mutations in the TPMT gene that 
reduce or abolish TPMT functions lead to decreased thiopurine drug 
methylation, resulting in cytotoxicity and cell death [4-7]. To 
understand the pharmacogenetics of TPMT and 6MP, X-ray co-
crystal structures of TPMT complexes with AdoHcy(CH2)6MP are 
required. However, the co-crystal structure of this complex has not 
been reported because 6MP is poorly water soluble [8]. To address 
this problem, we modeled the AdoHcy(CH2)6MP complex in the 
human TPMT active site and performed 1300 picoseconds (ps) 
molecular dynamic (MD) simulations to investigate the atomic 
interactions and dynamic properties of TPMT, AdoHcy, and 6MP.  
 
Methodology: 
Preparation of protein initial structure 
The X-ray crystal structure of the TPMT-AdoHcy complex was 
obtained from the Protein Data Bank (PDB identifier: 2H11). 
Missing atoms and missing residues identified in this structure were 
corrected using the SwissPdb program [9]. The structure of 6MP 
was retrieved from the ChemBank Database (ChemBank identifier: 
1116). 
 
Preparation of AdoHcy(CH2)6MP complex 
The X-ray crystal structure of murine TPMT, which is 77% 
identical to human TPMT, bound with AdoHcy and 6MP was 
recently published (PDB identifier: 3BGD) [10]. The intersulfur 
distance between AdoHcy and 6MP molecules is 3.41 Å, which is 
approximatly double the 1.85 Å length of a sulfur-carbon single 
bond, suggesting that the methyl group is directly transferred from 
the donor to the acceptor by SN2-like mechanism. 6MP interacts 
with AdoHcy by pointing its sulfur atom towards the sulfur atom of 
AdoHcy. These two sulfur atoms form a bridge through the CH2 
group in the middle. Previous human TPMT-6MP modeling study 
suggested that 6MP interacts with TPMT by forming water bridges 
using its nitrogen atoms at the pentagonal and hexagonal rings with 
the nitrogen atoms of  Lys32 and Arg226 side chains [8]  (Figures 
1A and 1B).  
 
The 6MP structure was manually placed in the human TPMT active 
site by adaptation of the potential binding modes previously 
suggested by crystallography [8]. The AdoHcy(CH2)6MP complex 
was modeled by adding a CH2 group to the sulfur atom of the 
AdoHcy structure.  The same carbon atom was then used as a 
reference point for placing the 6MP structure. The sulfur atom of 
the 6MP was placed next to the AdoHcy structure to form a bond 
with the reference carbon atom. Both structures were arranged on 
the same plane. Finally, atomic charges were assigned to the 
complex as shown in Figure 1C. The AdoHcy(CH2)6MP complex 
was used as an initial ligand structure for MD simulation and as a 
reference for root mean square deviation (RMSD) calculations for 
all AdoHcy(CH2)6MP trajectories. 
 
MD simulations 
The AMBER v.9 package [11, 12] was used to prepare  the protein 
and the ligand files as well as the MD simulations. Topology and 
parameter files for TPMT, AdoHcy, and 6MP were generated using 
“ff03” all-atom AMBER force field. The complex was solvated in 
the octahedron box of TIP3P water with 10 Å distance between the 
protein surface and the box boundary. Sodium and chloride ions 
were added to neutralize the system. The SHAKE algorithm [13] 
was applied to all bonds containing hydrogen atoms with the time 
step parameter set to 2 femtoseconds.  
 
The energy minimization and MD simulations were carried out 
using the SANDER program in the AMBER package. Three 
thousand energy minimization steps (steepest descent for 1000 steps 
and then conjugate gradient for 2000 steps) were applied to the 
initial TPMT-AdoHcy(CH2)6MP complex to relieve atomic clashes 
and bad contacts. After energy minimization, MD simulations were 
performed using protein-atom restrained simulations for 20 ps and a 
harmonic potential with a 10 kcal/mol force constant, followed by 
1300 ps all-atom unrestrained simulation. The trajectories of the 
entire system were recorded every 10 ps. The molecular dynamic of 
the complex was terminated when the simulation reached 1300 ps. Bioinformation   open access 
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The PDB structures of the last 100 ps were extracted from the MD 
simulated trajectories to generate the average structure, which was 
subsequently used for 6MP binding mode and the corresponding 
interaction analysis. 
 
Discussion: 
After the MD simulation, we calculated RMSDs between Cα of 
TPMT trajectories recorded every 10 ps and Cα of their X-ray 
crystal structure. The RMSDs for the trajectories of the 
AdoHcy(CH2)6MP complex were also calculated using its initial 
model as a reference structure. The results in Figure 2 show that the 
RMSDs of both TPMT and AdoHcy(CH2)6MP trajectories were 
always less than 1.50 Å for the entire simulation. The trajectories 
were not greatly different from the X-ray crystal structure, with only 
minor movements of the Cα of TPMT observed. This indicates that 
our simulation system was stable. The simulation length used in this 
study was long enough to allow rearrangement of TPMT side chains 
and the AdoHcy(CH2)6MP complex to find their most stable 
binding mode. 
 
We verified the quality of our model by using PROCHECK [14]. 
The results show that all protein residues were in the most favored 
regions (90.0%) or in the additional allowed regions (10.0%) with 
the overall PROCHECK score of -0.28, which was in the 
recommended range. The Ramachandran plot also indicates that our 
model is reasonable with respect to the overall folds and dihedral 
angles. The PDB trajectories of the complex may be obtained at 
http://www.biotec.or.th/GI/publication. 
 
Figure 3A depicts the binding mode of 6MP and its interactions 
with human TPMT and AdoHcy predicted using MD simulation. 
The binding modes and the interactions of AdoHcy with the amino 
acid side chains in the vicinity of the TPMT active site are similar to 
those observed in the X-ray crystal structures (2H11 and 3BGD). 
The RMSDs between Cα of our model and the published X-ray 
crystal structures of human TPMT and murine TPMT (2H11 and 
3BGD) are 1.28 Å and 1.24 Å, respectively.  
     
 
Figure 1: Possible binding modes and interactions of  6MP against TPMT and AdoMet previously suggested by crystallography [8] (A and 
B). We modeled the AdoHcy(CH2)6MP complex, where the sulfur atom of 6MP was placed next to the AdoMet structure, forming a bridge 
with the sulfur atom of AdoMet through the CH2 group (C). 
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Figure 2: Plot of root mean square deviation (RMSD) of Cα-TPMT (black) and AdoHcy-6MP complex (gray) trajectories against the initial 
model. The trajectories were captured every 10 ps until the simulation time reached 1300 ps. The RMSD of both structures are always < 
1.50 Å for the entire simulation indicating high stability of the complex. 
 
 
Figure 3: Binding mode and interactions of 6MP against TPMT and AdoHcy. From our MD simulations, the trajectory shows that 6MP 
interacts with AdoMet through the CH2 group by pointing its sulfur atom toward the sulfur atom of AdoMet and interacts with Phe40, 
Pro195, Pro196 and Arg226 of TPMT by non-bonded interactions (A). AdoHcy interacts with amino acid side chains lining in the TPMT 
active site, i.e. Trp33, Leu69, Cys70, Glu90, Ile91, Ile135 and Arg152, which consistent with those interactions observed in murine TPMT-
AdoHcy-6MP X-ray crystal structures (B) [10]. 
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The inter sulfur distance between AdoHcy and 6MP molecules of 
our model is 3.40 Å (Figure 3A), consistent with that of murine 
TPMT-AdoHcy-6MP X-ray crystal structure 3BGD (3.41 Å) 
(Figure 3B) [10]. Our model shows that the location of nitrogen 
atoms in the pentagonal ring (N3 and N4) of 6MP are positioned 
4.00 and 5.24 Å from Pro196 and Arg226 side chains while a 
nitrogen atom in the hexagonal ring (N1) is positioned 3.60 Å from 
Phy40 of TPMT (Figure 3A). These distances and the underlying 
conformation correspond with the murine TPMT-AdoHcy X-ray 
crystal structures in Figure 3B [10]. The binding modes of 6MP 
observed in our model and the X-ray crystal structure [10] also 
indicate that 6MP is stabilized in the TPMT active site by non-
bonded interactions with Phe40, Arg152, Pro195, Pro196, Arg226 
side chains.  
 
Enzymatic activity and mutagenesis studies of human TPMT 
mutants have shown that amino acid substitutions in the TPMT 
active site (Arg at residues 152 and 226 to Ala, Glu or His) alter the 
Km and Vmax values for 6MP [10]. Mutations of non-active-site 
residues (for example, residues 80, 132, 180 and 240) also greatly 
reduce the enzymatic activity of TPMT (to one third of the wild 
type activity) [8]. This information suggests that the dynamics of 
TPMT structure and structural distortion resulting from mutations 
of active-site and non-active-site residues play important roles in 
formation of TPMT-AdoHcy-6MP complex. The flexible loops in 
the TPMT structure have been proposed to contribute to structural 
rearrangements affecting ligand binding, TPMT function as well as 
enzymatic activity [8, 10]. However, loop rearrangement was not 
observed in our model. The MD simulation performed in this study 
was considerably too short to observe the movements of these 
loops.  
 
Conclusions: 
We used MD simulation to predict the structure of the complex of 
human TPMT-AdoHcy(CH2)6MP, where the sulfur atoms of 
AdoHcy and 6MP were linked by a CH2 group. After 1300 ps of 
MD simulation, the trajectory showed that 6MP was stabilized in 
the TPMT active site by formation of non-bonded interactions 
between 6MP and Phe40, Pro196 and Arg226 side chains of TPMT. 
The intersulfur distance between AdoHcy and 6MP as well as the 
binding modes and the interactions of our TPMT-AdoHcy model 
are consistent with those observed in the X-ray crystal structure of 
murine TPMT-AdoHcy-6MP complex. Our model provides 
structural insights into the interactions of TPMT, AdoHcy, and 6MP 
at the atomic level, which may be used as a starting point for further 
study of thiopurine drug pharmacogenetics. 
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